Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein
- Authors
- Lee, Hye-Ra; Choi, Won-Chan; Lee, Stacy; Hwang, Jungwon; Hwang, Eunha; Guchhait, Koushik; Haas, Juergen; Toth, Zsolt; Jeon, Young Ho; Oh, Tae-Kwang; Kim, Myung Hee; Jung, Jae U.
- Issue Date
- 12월-2011
- Publisher
- NATURE PUBLISHING GROUP
- Citation
- NATURE STRUCTURAL & MOLECULAR BIOLOGY, v.18, no.12, pp.1336 - U48
- Indexed
- SCIE
SCOPUS
- Journal Title
- NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Volume
- 18
- Number
- 12
- Start Page
- 1336
- End Page
- U48
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/111003
- DOI
- 10.1038/nsmb.2142
- ISSN
- 1545-9993
- Abstract
- Herpesvirus-associated ubiquitin-specific protease (HAUSP) regulates the stability of p53 and the p53-binding protein MDM2, implicating HAUSP as a therapeutic target for tuning p53-mediated antitumor activity. Here we report the structural analysis of HAUSP with Kaposi's sarcoma-associated herpesvirus viral interferon (IFN) regulatory factor 4 (vIRF4) and the discovery of two vIRF4-derived peptides, vif1 and vif2, as potent and selective HAUSP antagonists. This analysis reveals a bilateral belt-type interaction that results in inhibition of HAUSP. The vif1 peptide binds the HAUSP TRAF domain, competitively blocking substrate binding, whereas the vif2 peptide binds both the HAUSP TRAF and catalytic domains, robustly suppressing its deubiquitination activity. Peptide treatments comprehensively blocked HAUSP, leading to p53-dependent cell-cycle arrest and apoptosis in culture and to tumor regression in xenograft mouse model. Thus, the virus has developed a unique strategy to target the HAUSP-MDM2-p53 pathway, and these virus-derived short peptides represent biologically active HAUSP antagonists.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biotechnology and Bioinformatics > 1. Journal Articles
- College of Pharmacy > Department of Pharmaceutical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.